Skip to main content
HR 5122 114th Congress House

To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Introduced: July 13, 2016 See on congress.gov
Health Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug therapyMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 12, 2016
Referred to the Subcommittee on Health.
May 6, 2016
Referred to the Subcommittee on Health.
Apr 29, 2016
Introduced in House
Apr 29, 2016
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 12, 2016

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 13
All 13 Democratic 1 Republican 6
R
Guthrie, Brett
Kentucky · Sep 21, 2016
Nunes, Devin
· Sep 13, 2016
Comstock, Barbara
· Sep 9, 2016
 D
Aguilar, Pete
California · Jul 14, 2016
 R
Aderholt, Robert B.
Alabama · Jul 13, 2016
 R
Allen, Rick W.
Georgia · Jul 13, 2016
 R
Bilirakis, Gus M.
Florida · Jul 13, 2016
 R
Cole, Tom
Oklahoma · Jul 13, 2016
 R
Latta, Robert E.
Ohio · Jul 13, 2016
Paulsen, Erik
· Jul 13, 2016
TIBERI, PATRICK
· Jul 13, 2016
WALDEN, GREG
· Jul 13, 2016
SHIMKUS, JOHN
· Apr 29, 2016
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.. 114th Congress. Open America. https://openamerica.io/bill/114-HR-5122/
MLA
"H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-5122/.
Bluebook (legal)
H.R. 5122, 114th Cong. (2026), https://openamerica.io/bill/114-HR-5122/.
Markdown link
[H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.](https://openamerica.io/bill/114-HR-5122/)
Report a problem